Research Article

Prognostic Prediction Value of qSOFA, SOFA, and Admission Lactate in Septic Patients with Community-Acquired Pneumonia in Emergency Department

Table 1

Baseline characteristics of enrolled patients with CAP in ED.

All cohortDeathSurvivalICU admissionNon-ICU admission

N (%)33689 (26.5)247 (73.5)61 (18.2)275 (81.8)
Age (yrs)76 (61, 84)78 (67, 85)75 (61, 83)0.13681 (70, 88)74 (61, 83)0.003
Male, n (%)213 (63.4)56 (62.9)157 (63.6)0.91440 (65.6)173 (62.9)0.696
Comorbidities, n (%)
 COPD40 (11.9)12 (13.5)28 (11.3)0.59216 (26.2)24 (8.7)<0.001
 CDVD48 (14.3)18 (20.2)30 (12.1)0.06214 (23.0)34 (12.4)0.033
 CBVD88 (26.2)28 (31.5)60 (24.3)0.18718 (29.5)70 (25.5)0.515
 Diabetes77 (22.9)31 (34.8)46 (18.6)0.00224 (39.3)53 (19.3)0.001
 CRD30 (8.9)9 (10.1)21 (8.5)0.6488 (13.1)22 (8.0)0.205
 HBD24 (7.1)5 (5.6)19 (7.7)0.5154 (6.6)20 (7.3)0.844
 Healthy28 (8.3)6 (6.7)22 (8.9)0.5268 (13.1)20 (7.3)0.135
Laboratory results
 WBC (×109/L)10.0 (6.7, 14.1)11.0 (6.7, 15.9)9.8 (6.8, 13.9)0.40611.7 (7.5, 15.9)9.7 (6.6, 13.9)0.046
 HGB (g/L)126 (115, 137)123 (111, 134)127 (117, 138)0.125123 ± 22127 (117, 138)0.367
 HCT (%)36.9 (31.8, 40.8)34.7 ± 9.137.3 (32.9, 40.9)0.03735.5 ± 9.337.3 (32.5)0.368
 PLT (×109/L)184 (131, 251)163 (123, 249)191 (136, 251)0.311155 (123, 230)191 (137, 254)0.116
 ALB (g/L)36.2 (32.1, 39.1)34.0 ± 5.936.7 (33, 39.3)0.00134.3 ± 6.036.5 (32.5, 39.1)0.044
 CREA (μmol/L)80.5 (60.8, 114.3)92 (63.6, 140)75.9 (60.4, 105.8)0.01195.5 (74.6, 150)75.9 (60.2, 105)<0.001
 BUN (mmol/L)7.4 (5.3, 11.0)8.7 (6.0, 13.4)6.8 (5.1, 10.4)0.01010.4 (6.7, 16.1)6.8 (5.1, 10.4)<0.001
 AST (U/L)30 (20, 56)33 (23, 68)30 (20, 53)0.17436 (23, 64)30 (20, 54)0.240
 ALT (U/L)20 (14, 37)17 (12, 35)21 (14, 37)0.22516 (11, 32)21 (14, 38)0.167
 TBIL (μmol/L)14.8 (9.6, 23.0)15.3 (10.3, 23.5)14.3 (9.5, 22.7)0.31815.1 (9.6, 23.6)14.7 (9.8, 22.9)0.778
 DBIL (μmol/L)6.4 (4.0, 10.6)6.8 (4.4, 11.3)6.1 (3.8, 10.2)0.0896.1 (4.3, 11.5)6.4 (4.0, 10.4)0.503
 K+ (mmol/L)3.8 (3.5, 4.2)3.9 (3.5, 4.4)3.8 (3.5, 4.2)0.2524.0 (3.6, 4.4)3.8 (3.5, 4.2)0.050
 PaO2/FiO2303 (262, 352)285 (246, 328)313 (273, 363)<0.001286 (241, 328)310 (268, 361)0.007
Vital signs
 SBP (mmHg)132 (119, 139)122 (97, 135)134 (125, 143)<0.001122 (96, 135)132 (122, 142)<0.001
 DBP (mmHg)68 (65, 76)63 (55, 70)70 (66, 78)<0.00165 ± 1169 (65, 76)<0.001
 HR (times/min)86 (78, 94)87 (79, 106)86 (78, 94)0.00986 (79, 106)86 (78, 94)0.024
Severity scores
 CURB652 (2, 3)3 (3, 4)2 (1, 3)<0.0013 (3, 4)2 (2, 3)<0.001
 CRB652 (1, 3)3 (2, 3)2 (1, 2)<0.0013 (2, 3)2 (1, 2)<0.001
 PSI128 ± 40157 ± 35120 ± 38<0.001174 (150, 191)121 ± 36<0.001
 SOFA3 (2, 5)6 (4, 8)3 (2, 4)<0.0017 (6, 9)3 (2, 4)<0.001
 qSOFA2 (1, 2)3 (2, 3)1 (1, 2)<0.0013 (2, 3)1 (1, 2)<0.001
 Lactate (mmol/L)1.4 (1.1, 2.1)1.8 (1.3, 2.9)1.3 (1.1, 1.8)<0.0012.5 (1.6, 4.2)1.3 (1.1, 1.8)<0.001

Data are presented as n, n (%), or median (QL, QU). CAP: community-acquired pneumonia; ED: emergency department; SCAP: severe community-acquired pneumonia; NSCAP: nonsevere community-acquired pneumonia; COPD: chronic obstructive pulmonary disease; CDVD: cardiovascular disease; CBVD: cerebrovascular disease; CRD: chronic renal disease; HBD: hepatobiliary disease; WBC: white blood cell; HGB: hemoglobin; HCT: hematocrit; PLT: platelet; ALB: albumin; CREA: creatinine; BUN: blood urea nitrogen; AST: aspartate aminotransferase; ALT: alanine aminotransferase; TBIL: total bilirubin; DBIL: direct bilirubin; SBP: systolic blood pressure; DBP: diastolic blood pressure; HR: heart rate; CURB65: confusion, urea > 7 mmol/L, respiratory rate ≥ 30/min, blood pressure < 90 mmHg systolic and/or ≤60 mmHg diastolic, and age ≥ 65 years; CRB65: confusion, respiratory rate ≥ 30/min, blood pressure < 90 mmHg systolic and/or ≤60 mmHg diastolic, and age ≥ 65 years; PSI: pneumonia severity index; SOFA: sequential organ failure assessment; qSOFA: quick sequential organ failure assessment.